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Abstract: A robust literature, over the last years, supports the indication of cardiopulmonary exercise testing 
(CPET) in patients with cardiovascular diseases. Understanding exercise physiology is a crucial component of the 
critical evaluation of exercise intolerance. Shortness of breath and exercise limitation is often treated with an 
improper focus, partly because the pathophysiology is not well understood in the frame of the diagnostic spectrum 
of each subspecialty. A vital field and research area have been cardiopulmonary exercise test in heart failure with 
preserved/reduced ejection fraction, evaluation of heart failure patients as candidates for LVAD-Implantation, as 
well as for LVAD-Explantation and ultimately for heart transplantation. All the CPET variables provide synergistic 
prognostic discrimination. However, Peak VO2 serves as the most critical parameter for risk stratification and 
prediction of survival rate. 
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1. Introduction  
 CPET can simultaneously investigate the 
responses under the exercise of respiratory, cellular 
and cardiovascular systems. It is practically impossible 
to examine the heart or the lungs exclusively during 
exercise. There is always the need for coordination of 
both systems to meet the physiological demands in 
energy and oxygenation. The cardiopulmonary exercise 
test is unique in terms of combining ECG, 
measurement of gas exchange, blood pressure and 
spirometry. It has low morbidity and it is relatively 
inexpensive. Thus, it should be more often used in 
patients with both heart and lung diseases. The aim of 
this review is to get insight into the viability of 
cardiopulmonary exercise testing and to summarize the 
clinical applications in heart failure patients [1] as well 
as to demonstrate the utility in patients as candidates 
for LVAD implantation and explantation [2].  
 
2. Heart Failure with reduced/preserved 
ejection fraction  
 Two of the most studied variables in 
cardiopulmonary exercise tests are Peak VO2 and the 
VE/VCO2 slope. Both have secure independent 
prognostic value in the group of patients with systolic 
heart failure [3]. Exercise oscillatory ventilation (EOV) 
and the partial pressure of end-tidalCO2 (PETCO2) 
during rest and exercise have also demonstrated 
strong prognostic value in patients with systolic heart 
failure (HF) [4-7]. There is also evidence, which 
indicates that a percent-predicted peak VO2 value 
below 50% indicates a poor prognosis [8]. Peak VO2, 
the VE/VCO2 slope, presence/absence of EOV, and 
PETCO2 in rest or during exercise should all be 
assessed. Pathological values increase the likelihood of 
major and minor adverse events, such as death, HF 
decompensation to the refractory stage as well as 
hospitalization due to HF, which is also likely to 
increase. Multiple studies have demonstrated that the 
above-mentioned CPET variables respond favorably to 
pharmacological, surgical and lifestyle interventions in 
patients with systolic HF [3].  
 It should always be taken into consideration 
the clinical image and the hemodynamic parameters 
that may reflect increased severity and favor a worse 
outcome, such as an abnormal hemodynamic 
response, alterations of electrocardiogram (ECG) and 
an abnormally low HR recovery (HRR) at one minute 
post-ET [9-13]. CPET has a prognostic value in heart 
failure with preserved ejection fraction. This has been 
established from a Project, the so-called The Henry 
Ford Hospital Cardiopulmonary Exercise Testing (FIT-
CPX) project. Between 1997 and 2010, 173 Patients 
with HFpEF have been identified and included (45% 
women, 58% non-white, age 54 ± 14 years). Based on 
the Wald statistic from the Cox regression analyses 
adjusted for age, sex, and β-blockade therapy, 
ppMVO2 was the strongest predictor, followed by peak 
VO2. VE/VCO2 slope and EOV had no significant 
association [14]. CPET and echocardiography are 
considered as two essential tools for critical objective 
measurements concerning diastolic dysfunction.  
 In patients with chronic heart failure, CPET can 
detect a reduced peak VO2 and AT, reflecting reduced 
O2 transport. In the case of moderate to severe 
dysfunction, an increase in VE/VCO2 can be identified. 
Because the increase in VE/VCO2 is due to increased 
VD/VT in proportion to the reduction in exercise 
tolerance and is not accompanied by hypoxemia [15], 
these findings must reflect decreased perfusion. There 
are numerous studies comparing the CPET results 
between patients with reduced and preserved ejection 
fraction.  A survey from Farr et al. interpreted 
cardiopulmonary exercise testing and 
echocardiographic findings. The VE/VCO2 slope was 
higher in patients with HFpEF, with, however, no 
differences in peak VO2 [16].  
 Another study from Kitzman et al. 
demonstrated that patients aged at least 60 years with 
diastolic heart failure had similar abnormalities. Still, 
not as severe as by patients with systolic heart failure, 
such as reduced exercise performance, reduced quality 
of life (QoL) and neuroendocrine activation (e.g. 
Norepinephrine and brain natriuretic peptide) [17]. 
Focused on the ventilatory response, a study from 
Witte et al. reported a significantly higher VE/VCO2 
slope in heart failure patients with reduced ejection 
fraction compared with patients with preserved 
ejection fraction and an asymptomatic control group 
[18]. A critical study by Arruda et al. demonstrated 
that patients with diastolic heart failure had similar 
breathing patterns and gas exchange responses to 
patients with systolic heart failure. 
Echocardiographically observed, a large volume of left 
atrium or an altered E/E′ ratio were associated with 
reduced exercise capacity and elevated ventilatory 
responses, particularly in patients with HFpEF [19].  
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3. CPET as a tool for measurement of 
cardiac output, assessing and grading the 
severity of heart failure  
 In a study published in 2017 from Agostoni P 
et al., based on gender and age, cardiac output is 
correlated with peak VO2. An equation has been 
formed, that can provide and predict peaked cardiac 
output:  (4.4 × peak V˙o2) + 4.3 in the overall study 
cohort, (4.3 × peak V˙o2) + 4.5 in men, and (4.9 × 
peak V˙o2) + 3.6 in women [20]. A Study from 
Matsumura et al. demonstrated that the NYHA 
classification could be correlated with the AT and peak 
VO2, showing that symptoms and the ability to 
transport O2 were correlated [21]. Another Study from 
Weber and Janicki correlated more objectively the 
symptoms with peak VO2 and AT. An A through E 
Classification for VO2/kg has been established. It has 
been found that this classification for objectively 
assessing cardiac dysfunction was superior to NYHA 
Classification [22]. A consensus conference for patients 
with heart failure as candidates for heart 
transplantation agreed with this more objective 
assessment [23] (Table 1). 
 
Table 1 Most important parameters of CPET for 
heart failure patients 
Peak VO2(ml/kg/min) Maximal Oxygen 
Consumption 
VE/VCO2 Slope Ventilatory efficiency, 
normal < 30 
O2 Puls 
(ml/Heartbeat) 
Surrogate Value for 
cardiac output 
PetCO2 (mmHg) End-tidal CO2, normal > 
30 
Peak RER The ratio of exhaled CO2 
and inhaled O2 
 
3.1 Peak VO2 and Heart failure Prognosis  
 Over the last decades, it has been increasingly 
appreciated that peak VO2 more sensitively predicts 
prognosis than more classic heart failure risk factors 
such as left ventricular ejection fraction, NYHA Class IV 
symptoms and neurohormonal markers. 
 Increasing experience has confirmed the 
prognostic value of peak VO2 in the evaluation of 
patients with heart failure for cardiac transplantation 
[24-26]. A study from Weber et al. had demonstrated 
that, except maximal cardiac output during exercise, 
maximal peak VO2 is poorly correlated with cardiac 
index, wedge pressure (at rest or during exercise),  left 
ventricular ejection fraction and radiographic heart 
[27]. Szlachik et al. reported that peak VO2 of less 
than 10ml/min/kg predicted 77% 1-year mortality; if 
peak VO2 was between 10 and 18 ml/min/kg, 1-year 
mortality was only 14% [28]. Back in 2012, HF-
ACTION Trial demonstrated that for every 6% increase 
in peak VO2 (1 ml/kg/min), a 5% lower risk of 
mortality or hospitalization was observed [29]. 
 
3.2 Submaximal exercise parameters with high 
prognostic value  
 Anaerobic threshold (AT) represents the 
maximal sustainable VO2. It is an objective 
measurement and it can be derived from submaximal 
exercise testing without the need for maximal effort. 
Another Parameter that derives from submaximal 
testing and has a prognostic value for survival is the 
VE/VCO2 slope below the ventilator compensation 
point (VCP) [30-31]. A study from Gitt et al. has shown 
that peak VO2 and the submaximal parameters can 
serve as predictors of 6-month and 24-month patient 
survival rate in a cohort of 223 patients. As thresholds 
have been considered a peak VO2 of less than 14 
ml/min/kg, AT or less than 11 ml/min/kg and VE/VCO2 
slope below the VCP of more than 35 for high risk. It 
has been found that each of these parameters 
separates the high risk from low-risk patients [32]. The 
combination of AT and VE/ VCO2 below the VCP was 
found to be the best predictor of early death within 6 
months in patients with left ventricular failure. Because 
both AT and VE/VCO2 below the VCP are determined 
at submaximal work levels and are not effort 
dependent, these are exceptionally valuable 
measurements. Sun et al. confirmed the 6-month 
findings showing increased early death or 
hospitalization rates if values were beyond the 
threshold values for severity. When adding oscillatory 
breathing pattern in assessing survival in stable 
patients with heart failure, death and early 
hospitalization rates within six months were even more 
marked [33].  
 
4. Heart transplantation 
4.1 Risk stratification and survival rate based on 
VO2 measurement  
 Multiple studies have outlined the important 
significance of peak VO2, serving as the most powerful 
predictor for survival rate in heart failure patients, 
which are candidates for heart transplantation. One 
study demonstrated that peak VO2 outperformed right 
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heart catheterization data, exercise time, and the usual 
clinical variables used to assess heart failure patients in 
predicting outcomes. Direct measurement of VO2 
should be made when a clinical or surgical decision 
needs to be made. Another study demonstrated that a 
group of patients who referred for heart 
transplantation with stable congestive heart failure and 
who had peak VO2 of 17.4+/4.3ml/kg/min, had a 
survival rate at 1 year of 98% and at least 4 years of 
84%. This study had also demonstrated that patients 
have a favorable prognosis in case of stable symptoms 
and a relatively high peak exercise VO2 [34]. Macini et 
al. studied patients who were candidates for heart 
transplantation. Patients were divided based on peak 
VO2. Patients with peak VO2 greater than 14 
ml/kg/min were considered too well for transplantation 
and had a 1-year survival rate of 94%. Patients with 
peak VO2 less than 14 ml/kg/min were accepted for 
transplantation and had a 70% 1-year survival rate 
with medical management. There was also a group of 
patients with peak VO2 less than 14 ml/kg/min that 
were not accepted for surgery for non-cardiac reasons 
[35]. In a study from Osada et al., 154 of 500 patients 
have been identified, who were referred for cardiac 
transplantation, with a peak VO2 equal to or less than 
14ml/kg/min. In patients with an inability to reach a 
systolic blood pressure of 120mmHg, the 3-year 
survival rate was reduced from 83% to 55% [36].  
 
4.2 Proper treatment and re-evaluation of 
candidates for LV heart transplantation   
 Perhaps one of the most important studies, a 
landmark study from Stevenson et al. presented data 
on 68 heart transplantation candidates. All candidates 
repeated exercise tests at a mean 6 +/- months after 
initial evaluations. The goal was to determine the 
probability of excluding the patient for heart 
transplantation under optimizing heart failure 
treatment. All 68 patients were treated with the 
escalation of medical therapy, e.g. diuretics and 
afterload reduction. It was also addressed that all 68 
patients were involved in exercise rehabilitation 
training. Thirty patients had no significant 
improvement. However, 38 patients had an increase in 
peak VO2 of more than 2ml/kg/min, to a value greater 
than 12 ml/kg/min. Of these, 7 patients reported no 
clinical improvement, but 31 were clinically improved. 
The study also demonstrated that AT, peak O2 pulse 
and exercise heart rate reserve was improved and 
resting heart rate was decreased. 45% of the patients 
removed from the heart transplantation list, and the 
actual survival rate was 100% [37].  
4.3 Left ventricular assist device (LVAD)  
 Not all patients with an end-stage status can 
benefit from heart transplantation, due to the fact that 
the available donations are not sufficient for the 
demand. Over the last years, the implantation of left 
ventricular assist devices has been an important and 
effective alternative for the support of these patients in 
the long-term. Cardiopulmonary exercise test can  e 
used in order to determine the exercise capacity of 
heart failure patients after  V  - mplantation.   
prospective multicenter  tudy from  ay aum et. 
demonstrated the progressive improvement of the 
 eak V  o2 throughout the study period despite no 
change in peak LVAD flow and a progressive reduction 
in resting LVEF [38].  
 On the flip side of the coin, cardiopulmonary 
exercise test can be served as a tool for prediction for 
myocardial recovery and as a predictor for weaning of 
LVAD. In a study from Imamura et al., 33 patients 
were enrolled, after implantation of ECPF-LVAD and 
symptom-limited CPX testing at three months after the 
operation, and who were followed  etween 2005 and 
2014.  ox regression analysis, E1 (maximum load 
 51 ), E2 (minute ventilation/car on dioxide output 
[V  E/V    2  slope  34), and E3 (peak oxygen 
consumption [ V   2   12.  ml kg(-1)·min(-1)) 
significantly predicted explantation expectancy during 2 
years after LVAD implantation (P<0.05 for all). 
Explantation score, the sum of positive E1-3, 
significantly stratified 2-year cumulative explantation 
rate into low (0 points), intermediate (1-2 points), and 
high (3 points) expectancy groups (0%, 29%, and 
86%, respectively, P<0.001). When the scoring system 
was used for 45 patients with continuous-flow LVAD, 
the 2 patients who had explantation were assigned to 
the high expectancy group [39].  
 
5. Conclusion and future aspects  
 Circulating metabolites and mRNAs in 
combination with CPET may provide valuable 
information and enlighten the genetic background as 
well as discover an initial stage of heart failure. The 
cardiopulmonary exercise test is potentially a potent 
diagnostic tool in cardiology. Combining numerous 
variables, blood gases, continuous ECG recording, 
blood pressure and heart rate monitoring, blood lactate 
and, in case of the invasive cardiopulmonary exercise 
test, measurement of invasive hemodynamic 
parameters, this test provides a wide spectrum of 
multiple diagnostic schemas in many different clinical 
cases. Heart failure accounts for one of the most 
Vol 9 Iss 2 Year 2020                Sakellaropoulos S, Lekaditi D, Svab S / 2020 
 Int. J. Phys. Educ. Fit. Sports, 9(2) (2020) 1-8 | 5 
important health issues worldwide. In cases whereby 
medical therapy, invasive and non-invasive therapeutic 
approaches as also as mechanical (such as left 
ventricular assist device) and resynchronization 
therapy, fail to improve outcome, heart transplantation 
may be the very last option. Perhaps as underused and 
underestimated diagnostic approach in clinical basis, 
cardiopulmonary exercise testing can essentially refine 
the grading of severity, prognosis and risk stratification 
of heart failure patients and can genuinely evaluate 
candidates for LVAD implantation and explantation. 
 
Appendix 
AT     Anaerobic Threshold  
CPET Cardiopulmonary exercise testing  
CRT      Cardiac resynchronization therapy  
EC-PF/-CF Extracorporal-pulsatile flow/ -continuous flow 
EOV     Exercise oscillatory ventilation  
HFpEF   Heart Failure with preserved Ejection Fraction 
HFrEF   Heart Failure with reduced Ejection Fraction  
HRR      Heart Rate recovery  
LV      Left Ventricle  
LVAD Left ventricular assist device 
LVEDD   Left ventricular end diastolic diameter  
LVAD     Left Ventricular assist device  
NYHA  New York Heart Association  
PAP      Pulmonary artery pressure  
PAWP    Pulmonary artery wedge pressure  
PETCO2 Partial pressure of end-tidalCO2  
QoL      Quality of Life  
RV      Right Ventricle  
SCD      Sudden cardiac death  
VCO2  Carbon dioxide output  
VE      Ventilation  
VO2      Oxygen uptake  
VD/VT   Dead space over tidal volume  
VCP    Ventilator compensation point  
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